Transglutaminase 2 and neuroinflammation

[1]  Yih-Ru Wu,et al.  Plasma inflammatory biomarkers for Huntington’s disease patients and mouse model , 2015, Brain, Behavior, and Immunity.

[2]  M. Cambron,et al.  Astrocyte loss and astrogliosis in neuroinflammatory disorders , 2014, Neuroscience Letters.

[3]  R. Eckert,et al.  Transglutaminase regulation of cell function. , 2014, Physiological reviews.

[4]  R. Takahashi,et al.  Transglutaminase 2 accelerates neuroinflammation in amyotrophic lateral sclerosis through interaction with misfolded superoxide dismutase 1 , 2014, Journal of neurochemistry.

[5]  E. Hirsch,et al.  Heat shock protein 60: an endogenous inducer of dopaminergic cell death in Parkinson disease , 2014, Journal of Neuroinflammation.

[6]  S. Condello,et al.  Transglutaminase 2 and phospholipase A2 interactions in the inflammatory response in human Thp-1 monocytes , 2013, Amino Acids.

[7]  J. Schmid,et al.  The complexity of NF-κB signaling in inflammation and cancer , 2013, Molecular Cancer.

[8]  M. Dalakas.  Pathophysiology of autoimmune polyneuropathies. , 2013, Presse medicale.

[9]  A. Stepanova,et al.  Factors Affecting Aggregate Formation in Cell Models of Huntington’s Disease and Amyotrophic Lateral Sclerosis , 2013, Acta naturae.

[10]  M. Oh,et al.  Acacetin Attenuates Neuroinflammation via Regulation the Response to LPS Stimuli In Vitro and In Vivo , 2012, Neurochemical Research.

[11]  G. Johnson,et al.  Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia , 2012, Neurobiology of Disease.

[12]  Xiaoling Li,et al.  Characterization of Heparin-binding Site of Tissue Transglutaminase , 2012, The Journal of Biological Chemistry.

[13]  A. Belkin,et al.  Cellular functions of tissue transglutaminase. , 2012, International review of cell and molecular biology.

[14]  Jiankun Cui,et al.  Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1/2, iNOS and sPLA2-IIA expression in astrocytes and microglia , 2011, Journal of Neuroinflammation.

[15]  S. Condello,et al.  Transglutaminase 2 interaction with small heat shock proteins mediate cell survival upon excitotoxic stress , 2011, Amino Acids.

[16]  J. Bol,et al.  Astrocyte-Derived Tissue Transglutaminase Interacts with Fibronectin: A Role in Astrocyte Adhesion and Migration? , 2011, PloS one.

[17]  L. Rodrigo,et al.  Prevalence of celiac disease in multiple sclerosis , 2011, BMC neurology.

[18]  T. Luedde,et al.  NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma , 2011, Nature Reviews Gastroenterology &Hepatology.

[19]  J. Bol,et al.  Appearance of Tissue Transglutaminase in Astrocytes in Multiple Sclerosis Lesions: A Role in Cell Adhesion and Migration? , 2011, Brain pathology.

[20]  R. Ientile,et al.  Potential of transglutaminase 2 as a therapeutic target , 2010, Expert opinion on therapeutic targets.

[21]  S. Condello,et al.  Transglutaminase 2 silencing reduced the beta-amyloid-effects on the activation of human THP-1 cells , 2010, Amino Acids.

[22]  C. Colton,et al.  Assessing activation states in microglia. , 2010, CNS & neurological disorders drug targets.

[23]  T. Möller,et al.  Distinct neuroinflammatory profile in post-mortem human Huntington's disease , 2009, Neuroreport.

[24]  Mark A Horswill,et al.  Transglutaminases and neurodegeneration , 2009, Journal of neurochemistry.

[25]  E. Hirsch,et al.  Neuroinflammation in Parkinson's disease: a target for neuroprotection? , 2009, The Lancet Neurology.

[26]  M. Hayden,et al.  A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease , 2008, The Journal of experimental medicine.

[27]  A. Verma,et al.  Transglutaminase-mediated activation of nuclear transcription factor-kappaB in cancer cells: a new therapeutic opportunity. , 2007, Current cancer drug targets.

[28]  N. Muma.  Transglutaminase Is Linked to Neurodegenerative Diseases , 2007, Journal of neuropathology and experimental neurology.

[29]  R. Ientile,et al.  Tissue transglutaminase and the stress response , 2007, Amino Acids.

[30]  S. Bauer,et al.  The neuropoietic cytokine family in development, plasticity, disease and injury , 2007, Nature Reviews Neuroscience.

[31]  F. Licastro,et al.  Age‐Related Inflammatory Diseases , 2006 .

[32]  Soo-Youl Kim,et al.  Transglutaminase 2 in inflammation. , 2006, Frontiers in bioscience : a journal and virtual library.

[33]  D J Brooks,et al.  Microglial activation correlates with severity in Huntington disease , 2006, Neurology.

[34]  K. Roth,et al.  Tissue transglutaminase overexpression in the brain potentiates calcium‐induced hippocampal damage , 2006, Journal of neurochemistry.

[35]  T. Klockgether,et al.  Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms , 2006, International Journal of Developmental Neuroscience.

[36]  J. J. Moreno.  Effects of antiflammins on transglutaminase and phospholipase A2 activation by transglutaminase. , 2006, International immunopharmacology.

[37]  F. Licastro,et al.  Age-related inflammatory diseases: role of genetics and gender in the pathophysiology of Alzheimer's disease. , 2006, Annals of the New York Academy of Sciences.

[38]  L. Larocca,et al.  Characterization of cell death pathways in human immunodeficiency virus-associated encephalitis. , 2005, The American journal of pathology.

[39]  J. Wess,et al.  Regulation of CD8+ cytolytic T lymphocyte differentiation by a cholinergic pathway , 2005, Journal of Neuroimmunology.

[40]  M. Block,et al.  Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism , 2005, Progress in Neurobiology.

[41]  J. O'Callaghan,et al.  Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity , 2005, Expert opinion on drug safety.

[42]  K. Tracey,et al.  Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation , 2005, The Journal of experimental medicine.

[43]  F. Block,et al.  Inflammation in areas of remote changes following focal brain lesion , 2005, Progress in Neurobiology.

[44]  J. Hubbell,et al.  Neurite extension and in vitro myelination within three-dimensional modified fibrin matrices. , 2005, Journal of neurobiology.

[45]  C. Ross,et al.  Mutant Huntingtin Protein: A Substrate for Transglutaminase 1, 2, and 3 , 2005, Journal of neuropathology and experimental neurology.

[46]  M. Merville,et al.  Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. , 2005, Trends in biochemical sciences.

[47]  M. Merville,et al.  Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation , 2005 .

[48]  G. Li Volti,et al.  Glutamate‐evoked redox state alterations are involved in tissue transglutaminase upregulation in primary astrocyte cultures , 2004, FEBS letters.

[49]  T. Joh,et al.  Transglutaminase 2 induces nitric oxide synthesis in BV-2 microglia. , 2004, Biochemical and biophysical research communications.

[50]  T. Joh,et al.  Transglutaminase 2 induces NF-κB activation via a novel pathway in BV-2 microglia , 2004 .

[51]  G. Li Volti,et al.  Excitotoxic and post-ischemic neurodegeneration: Involvement of transglutaminases , 2004, Amino Acids.

[52]  G. Calapai,et al.  Transglutaminase activity and transglutaminase mRNA transcripts in gerbil brain ischemia , 2004, Neuroscience Letters.

[53]  C. Brosnan,et al.  Interleukin-1β Induces a Reactive Astroglial Phenotype via Deactivation of the Rho GTPase–Rock Axis , 2004, The Journal of Neuroscience.

[54]  G. Li Volti,et al.  Cystamine inhibits transglutaminase and caspase‐3 cleavage in glutamate‐exposed astroglial cells , 2003, Journal of neuroscience research.

[55]  S. Henriksen,et al.  Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS. , 2003, The American journal of pathology.

[56]  Robert M. Graham,et al.  Transglutaminases: crosslinking enzymes with pleiotropic functions , 2003, Nature Reviews Molecular Cell Biology.

[57]  S. Rivest.  Molecular insights on the cerebral innate immune system , 2003, Brain, Behavior, and Immunity.

[58]  C. Ross,et al.  Transglutaminase Cross‐Links in Intranuclear Inclusions in Huntington Disease , 2003, Journal of neuropathology and experimental neurology.

[59]  K. Santacruz,et al.  Injury‐induced ‘switch’ from GTP‐regulated to novel GTP‐independent isoform of tissue transglutaminase in the rat spinal cord , 2002, Journal of neurochemistry.

[60]  E. Major,et al.  HIV-1 and the brain: connections between HIV-1-associated dementia, neuropathology and neuroimmunology. , 2002, Microbes and infection.

[61]  K. Santacruz,et al.  Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration , 2002, Neurochemistry International.

[62]  D. Butterfield,et al.  Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists. , 2002, Journal of Alzheimer's disease : JAD.

[63]  J. Barretina,et al.  Human Immunodeficiency Virus 1 Envelope Glycoprotein Complex-Induced Apoptosis Involves Mammalian Target of Rapamycin/Fkbp12-Rapamycin–Associated Protein–Mediated P53 Phosphorylation , 2001, The Journal of experimental medicine.

[64]  S. Rivest,et al.  Toll‐like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram‐negative bacterial cell wall components , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[65]  J. Barretina,et al.  Human Immunodeficiency Virus 1 Envelope Glycoprotein Complex-induced Apoptosis Involves Mammalian Target of Rapamycin / FKBP 12-Rapamycin – associated Protein – mediated p 53 Phosphorylation , 2001 .

[66]  C. Yiannoutsos,et al.  NFKB activation, TNF-α expression, and apoptosis in the AIDS-Dementia-Complex , 2000 .

[67]  C. Yiannoutsos,et al.  NFkappaB activation, TNF-alpha expression, and apoptosis in the AIDS-Dementia-Complex. , 2000, Journal of neurovirology.

[68]  D. Price,et al.  Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Kazuhito Ogawa,et al.  Transglutaminase activity in serum and cerebrospinal fluid in sporadic amyotrophic lateral sclerosis: A possible use as an indicator of extent of the motor neuron loss , 1998, Journal of the Neurological Sciences.

[70]  M. Zern,et al.  TNF-α modulates expression of the tissue transglutaminase gene in liver cells. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[71]  M. Zern,et al.  TNF-alpha modulates expression of the tissue transglutaminase gene in liver cells. , 1998, The American journal of physiology.

[72]  R. Sasaki,et al.  Increase caused by interleukin-6 in promoter activity of guinea pig liver transglutaminase gene. , 1994, Bioscience, biotechnology and biochemistry.

[73]  P. Baeuerle,et al.  Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-kappa B. TNF alpha is not needed for induction of a biological effect via TNF receptors. , 1990, The Journal of biological chemistry.